Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Johnson & Johnson Development Corporation (JJDC) is the strategic venture capital arm of Johnson & Johnson, focused on investing in innovative life science and healthcare companies. Established in 1973, JJDC identifies and invests in early-stage ventures that align with J&J's core business sectors, including Pharmaceuticals, MedTech, and Consumer Health. The firm provides not only financial capital but also access to J&J's extensive global R&D, manufacturing, and commercialization expertise. JJDC's portfolio spans a wide range of therapeutic areas, medical devices, and digital health solutions, aiming to drive breakthroughs that address significant unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Johnson Development.